ATAI
Atai Beckley N.V.Company Information
- Company Name
- Atai Beckley N.V.
- CIK
- CIK0001840904
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ATAI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ATAI
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-14
- Last sale
- 2025-03-21
- Shares purchased (TTM)
- 21,311,517
- Shares sold (TTM)
- 182,250
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 46,893,825
- Shares outstanding
- 108,800,748
- Ownership
- 43.10%
Earnings Market Reaction
- Filing date
- 2025-11-12
- Price on filing date
- —
- 1-month reaction
- -0.23%
- 3-month reaction
- -13.16%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 30 | 62 | 48 | 18 | 30 | 19 | 19 | 45 | 76 | 141 | 186 | 191 | ||||||
| Restricted Cash And Investments Current | 0 | 0 | 10 | 10 | 15 | 15 | 5 | 0 | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 6 | 7 | 8 | 8 | 7 | 5 | 6 | 6 | 7 | 6 | 9 | 14 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | 0 | 6 | 2 | 1 | 1 | - | 9 | 9 | 0 | ||||||
| Notes Receivable Fair Value Disclosure | 10 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 131 | 103 | 116 | 80 | 114 | 118 | 118 | 186 | 216 | 243 | 268 | 287 | ||||||
| Restricted Cash And Investments Noncurrent | - | - | - | - | - | - | 10 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Equity Method Investments | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Restricted Investments At Fair Value | 34 | 17 | 23 | 29 | 45 | 61 | 90 | 90 | 72 | - | - | 0 | ||||||
| Other Long Term Investments | 54 | 54 | 42 | 42 | 34 | 32 | 33 | 2 | 4 | 4 | 6 | 7 | ||||||
| Notes Receivable Related Parties Noncurrent | - | - | - | - | - | - | - | - | - | 1 | 1 | 7 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 3 | - | - | - | 2 | - | - | - | - | ||||||
| Goodwill | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Notes And Loans Receivable Net Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 10 | - | - | 7 | ||||||
| Notes Receivable By Owner To Limited Liability Company L L C | - | - | - | 0 | 0 | 0 | 14 | 11 | 2 | - | - | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 1 | 3 | 3 | 3 | 3 | ||||||
| Assets | 240 | 189 | 196 | 159 | 198 | 216 | 269 | 293 | 308 | 254 | 281 | 305 | ||||||
Liabilities Current | ||||||||||||||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Accounts Payable Current | 5 | 4 | 3 | 3 | 5 | 4 | 4 | 5 | 6 | 4 | 5 | 2 | ||||||
| Accrued Liabilities Current | 10 | 15 | 9 | 10 | 12 | 13 | 11 | 15 | 13 | 13 | 14 | 17 | ||||||
| Business Combination Contingent Consideration Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Other Long Term Debt Current | 0 | 0 | 11 | 6 | - | - | - | 0 | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 2 | 3 | 0 | 1 | - | 0 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Current | 17 | 26 | 29 | 25 | 20 | 18 | 15 | 20 | 20 | 18 | 20 | 20 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 2 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Long Term Debt | 0 | 0 | 9 | 14 | 20 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||
| Other Liabilities Noncurrent | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 3 | 3 | 3 | 4 | ||||||
| Liabilities | 80 | 45 | 44 | 43 | 51 | 47 | 46 | 49 | 40 | 38 | 40 | 40 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 27 | 24 | 22 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | ||||||
| Additional Paid In Capital | 969 | 895 | 876 | 816 | 808 | 803 | 801 | 795 | 799 | 792 | 783 | 774 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -21 | -21 | -19 | -18 | -20 | -19 | -19 | -19 | -19 | -21 | -21 | -22 | ||||||
| Retained Earnings Accumulated Deficit | -815 | -754 | -727 | -700 | -661 | -635 | -578 | -551 | -533 | -577 | -544 | -510 | ||||||
| Stockholders Equity | 160 | 144 | 152 | 117 | 146 | 169 | 223 | 243 | 266 | 213 | 237 | 261 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | ||||||
| Liabilities And Stockholders Equity | 240 | 189 | 196 | 159 | 198 | 216 | 269 | 293 | 308 | 254 | 281 | 305 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.12 | 0.12 | 0.11 | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | ||||||
| Common Stock Shares Authorized | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | ||||||
| Common Stock Shares Issued | 120 | 106 | 100 | 84 | 84 | 84 | 83 | 83 | 83 | 83 | 83 | 83 | ||||||
| Shares Outstanding | 120 | 106 | 100 | 84 | 84 | 84 | 83 | 83 | 83 | 83 | 83 | 83 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAtai Beckley N.V. (ATAI) — SEC Financial Statements & Analysis
Atai Beckley N.V. (ATAI) is a pharmaceutical preparations company, incorporated in P7. Atai Beckley N.V. trades on Nasdaq as: ATAI. Atai Beckley N.V. (ATAI)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12. Based on that filing, Atai Beckley N.V. carries a market cap of $575.56M, a P/E ratio of -3.75x, a P/B ratio of 3.60x, a P/S ratio of 190.71x, an enterprise value of $545.15M, and an EV/EBITDA multiple of -5.27x. On profitability, it posts a gross margin of 945.86%, an operating margin of -3457.72%, a net margin of -5087.91%, a Return on Equity (ROE) of -100.48%, a Return on Assets (ROA) of -70.22%, and a Return on Invested Capital (ROIC) of -83.16%. Per share, it reports EPS of $-1.41, diluted EPS of $-1.41, free cash flow per share of $-0.74, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 811.78% year-over-year, net income growth of 20.25% year-over-year, and EPS growth of -11.23% year-over-year. On the balance sheet, it maintains a current ratio of 7.90x, a quick ratio of 7.54x, working capital of $114.12M, a debt-to-equity ratio of 0.50x, a debt ratio of 0.33, an interest coverage ratio of -49.32x, free cash flow of $-80.29M (TTM), and net debt of $-30.40M. Figures sourced from SEC EDGAR.
- Market Cap
- $575.56M
- P/E TTM
- -3.75x
- EPS TTM
- $-1.41
- P/B TTM
- 3.60x
- ROE TTM
- -100.48%
- ROA TTM
- -70.22%
- Debt To Equity
- 0.50x
- Free Cash Flow TTM
- $-80.29M
- Net Revenue TTM Growth 1Y
- 811.78%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Atai Beckley N.V. in?
Atai Beckley N.V. (ATAI) operates in the Pharmaceutical Preparations industry.
What exchange does ATAI trade on?
Atai Beckley N.V. (ATAI) trades on the Nasdaq.
Where is Atai Beckley N.V. incorporated?
Atai Beckley N.V. is incorporated in Netherlands.
When was Atai Beckley N.V. (ATAI)'s most recent SEC filing?
Atai Beckley N.V. (ATAI)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12.
What is ATAI's market cap?
Atai Beckley N.V. (ATAI) has a market capitalization of $575.56M as of 2025-09-30.
What is ATAI's EPS (earnings per share)?
Atai Beckley N.V. (ATAI)'s trailing twelve month EPS is $-1.41 as of 2025-09-30.
What is ATAI's ROE (return on equity)?
Atai Beckley N.V. (ATAI)'s trailing twelve month Return on Equity (ROE) is -100.48% as of 2025-09-30.
What is ATAI's ROA (return on assets)?
Atai Beckley N.V. (ATAI)'s trailing twelve month Return on Assets (ROA) is -70.22% as of 2025-09-30.
What is ATAI's ROIC (return on invested capital)?
Atai Beckley N.V. (ATAI)'s trailing twelve month Return on Invested Capital (ROIC) is -83.16% as of 2025-09-30.
What is ATAI's EV/EBITDA?
Atai Beckley N.V. (ATAI)'s trailing twelve month EV/EBITDA is -5.27x as of 2025-09-30.